KARKUCAK, M. Et Al. 2016. Anti TNF – ? therapy provides beneficial effects on choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism of infliximab effectiveness in suppressing uveitis attacks.. EULAR , (London, United Kingdom), 817.

KARKUCAK, M., KALKISIM, A., KOLA, M., ÇAPKIN, E., TÜRK, A., & AYAR, A., (2016). Anti TNF – ? therapy provides beneficial effects on choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism of infliximab effectiveness in suppressing uveitis attacks. . EULAR (pp.817). London, United Kingdom

KARKUCAK, MURAT Et Al. "Anti TNF – ? therapy provides beneficial effects on choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism of infliximab effectiveness in suppressing uveitis attacks.," EULAR, London, United Kingdom, 2016

KARKUCAK, MURAT Et Al. "Anti TNF – ? therapy provides beneficial effects on choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism of infliximab effectiveness in suppressing uveitis attacks.." EULAR , London, United Kingdom, pp.817, 2016

KARKUCAK, M. Et Al. (2016) . "Anti TNF – ? therapy provides beneficial effects on choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism of infliximab effectiveness in suppressing uveitis attacks.." EULAR , London, United Kingdom, p.817.

@conferencepaper{conferencepaper, author={MURAT KARKUCAK Et Al. }, title={Anti TNF – ? therapy provides beneficial effects on choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism of infliximab effectiveness in suppressing uveitis attacks.}, congress name={EULAR}, city={London}, country={United Kingdom}, year={2016}, pages={817} }